STEPHY.T.P, SREEJITH. K and Dr. BINDU G (2017) “Comparison of quality of life (QOL) for patients with breast Cancer receiving adjuvant tac (docetaxel, doxorubicin, Cyclophosphamide) and fac (5-fluorouracil, doxorubicin, Cyclophosphamide) therapy”, International Journal of Pharma and Bio Sciences, 8(3), pp. 373–382. doi: 10.22376/ijpbs.2017.8.3.p373-382.